NIH-funded research U01 cooperative agreement

Understanding how vaccines work in real life against flu and COVID-19

Official title: RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World

Funded at Washington University · NIH-11381364 · Data updated 2026-11-12

A real-world study at a major university hospital will track how well flu and COVID-19 vaccines protect ambulatory patients who have respiratory infections.

More Respiratory Tract Infections research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2027
Funding year2026
Award (this year)$1,550,000
NIH project number5U01IP001182-05
Project IDNIH-11381364 on NIH RePORTER

Who could benefit from this research

Could help

Ambulatory patients with acute respiratory illnesses who can participate in recruitment and sample collection.

Less likely to help

Patients who do not have respiratory infections or cannot participate in sample collection may not benefit.

What this research studies

This project uses real-world data from outpatient visits to measure how well influenza and SARS-CoV-2 vaccines perform when people develop respiratory illnesses. The team combines emergency medicine, pediatrics, epidemiology, informatics, and lab science to recruit patients, collect samples, and analyze vaccine effects using a test-negative design. Participants will provide respiratory and blood samples, and data will be pulled from electronic medical records to assess outcomes. The research plan focuses on rapid recruitment aligned with viral circulation and thorough quality checks to ensure reliable results.

Why it matters

Potential benefit: If successful, the study could clarify how well current vaccines protect people in everyday settings and inform public health vaccination strategies.

How similar studies have gone: Previous studies using test-negative designs have shown valuable insights into vaccine effectiveness in real-world settings.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: House, Stacey — Washington University
  • Study coordinator: House, Stacey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.